InvestorsHub Logo
icon url

d4diddy

04/18/13 4:53 PM

#39929 RE: Crow3 #39928

The iG4 will still be, if delivered, a medical instrument for a highly niche market just as the original Valimed has been.

And just as its predecessor, I believe that the iG4 will not perform as CDEx and pennstreet (their defacto message board spokesperson) claim.

icon url

Crow3

04/18/13 4:55 PM

#39930 RE: Crow3 #39928

It would take more money than CDEX has left over from the LUBBOCK bunch to mount a sales campaign. MUCHO MORE!!! That old saw about building a better mousetrap and the world would come a knocking does not apply here. It ain't a better mousetrap and any demand would be specialized and limited to pharmacies.

As with the VALIMED # 1, pharmacies are not gonna lay out a pile of money on an unproven DOO HICKEY...Even if the Hospital ADMINS would let them.